CAS RN: 42969-65-3

(R)-(+)-3-Butyn-2-ol

Product Availability

Choose a grade to view its available package options.

1 package records1 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260303 1g / 5g / 25g Confirm by inquiry Shanghai, Shandong Inquiry
  • Product code: SSC-151269
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 10g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 42969-65-3
Pack Size Recorded Purity Available Qty Ship From Inquiry
10g ≥95% 0 Out of Stock Shanghai Inquiry

42969-65-3 / but-3-yn-2-ol

Standard CAS: 42969-65-3 Multi CAS: Yes

Basic Information

CAS
42969-65-3
Multi CAS
Yes
Molecular Formula
C4H6O
Molecular Weight
70.090000
Exact Mass
70.041865
InChI
InChI=1S/C4H6O/c1-3-4(2)5/h1,4-5H,2H3
InChIKey
GKPOMITUDGXOSB-UHFFFAOYSA-N

Physical Properties

Physical Description
Colorless or light yellow liquid
State
Liquid

Computed Properties

Structural Parameters

Heavy atom count
5
Fraction Csp3
0.5
H-bond acceptors
1
H-bond donors
1
Molar refractivity
20.51
TPSA
20.23

LogP / Solubility

MLOGP
-0.02
XLogP3
0.1
Consensus LogP
0.03
Log S (ESOL)
-0.27
Class (ESOL)
Very soluble
Log S (Ali)
-0.14
Class (Ali)
Very soluble
Log S (SILICOS-IT)
-0.12
Class (SILICOS-IT)
Very soluble

ADME

GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.15

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
1.5

Get In Touch

Contact Us